Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
As-needed budesonide/formoterol with or without maintenance therapy for asthma in South African children
PACTR202502547023775Phase 3Recruiting
- Sponsor
- Dr Pinkie Mekgwe
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of budesonide + formoterol in asthma (3 arms), sponsored by Dr Pinkie Mekgwe. Primary endpoint: Number of severe asthma exacerbations in the treatment year. Started Jan 2024; status: recruiting.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on PACTR202502547023775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502547023775.